Dexamethasone Sodium Phosphate Injection
Product Images NDC 51662-1297

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Dexamethasone Sodium Phosphate (NDC 51662-1297). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Hf Acquisition Co Llc, Dba Healthfirst, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Pouch Labeling (00351662129722 Dexamethasone Pouch Label)

Label for Dexamethasone Sodium Phosphate Injection 4 mg/mL in a 5 mL vial. The package label includes the NDC 51662-1297-2, lot number 12345, and expiration date 2025-01-01. It states routes of administration as intravenous, intramuscular, intralesional, intra-articular, and soft tissue. The label advises storage between 20°C to 25°C, avoiding freezing and light exposure, and notes the product is prescription only. Manufactured by HF Acquisition Co., LLC, Mukilteo, WA.*

FDA Label Image

Case Rfid Label (00351662129739 Dexamethasone Rfid Label (1))

A Data Matrix barcode label for Dexamethasone Sodium Phosphate Injection distributed by HF Acquisition Co., LLC. The label includes GS1 formatted application identifiers with the product GTIN, expiration date, serial number, and lot number. It also instructs to see the manufacturer's package insert and indicates Rx use only.*

FDA Label Image

Case Labeling (00351662129739 Dexamethasone Case Label)

Label for Dexamethasone Sodium Phosphate Injection USP 20 mg per 5 mL (4 mg/mL) 5 mL vial, available in a box of 25. The label shows NDC 51662-1297-3, lot number 12345, and expiration date 2025-01-01. Manufactured by HF Acquisition Co LLC, Mukilteo, WA 98275. The product is indicated for intravenous, intramuscular, intralesional, intra-articular, or soft tissue use.*

FDA Label Image

Structure (Description Structure)

Chemical structure of dexamethasone sodium phosphate, showing the steroid backbone with attached sodium phosphate group and associated hydroxyl, methyl, and fluorine substitutions.*

FDA Label Image

Serialized Vial (Serialized Vial)

Dexamethasone Sodium Phosphate Injection, USP 20 mg/5 mL (4 mg/mL) in a 5 mL amber glass vial with a pink cap. The vial label states routes of administration including IV, IM, intralesional, intra-articular, or soft tissue use. A white label with barcodes and text is partially visible beside the vial, indicating distribution by HF Acquisition Co., LLC.*

FDA Label Image

Vial Label (Vial Label)

Label for Dexamethasone Sodium Phosphate Injection USP 20 mg/5 mL (4 mg/mL) in a 5 mL vial. The label includes dosage form, concentration, and administration routes: IV, IM, intralesional, intra-articular, or soft tissue use. It also displays storage instructions and the manufacturer, West-Ward, based in Eatontown, NJ.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.